Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zai Lab raises $30mm in Series C round

Executive Summary

Zai Lab Ltd. (Chinese biopharmaceutical company) raised $30mm in its Series C financing round. The round was led by OrbiMed along with additional new investors Vivo Capital, Cormorant, and Rock Springs Capital. The company will use the offering proceeds to fund its R&D and for future partnering. Back in 2016, Zai raised a large B round at $100mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies